Dietz Thomas John 4
4 · LEAP THERAPEUTICS, INC. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
Dietz Thomas John
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-29+30,000→ 30,000 totalExercise: $2.68Exp: 2034-01-29→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.